查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1873337

全球医院感染控制市场

Hospital Acquired Infection Control
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 246 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

全球医院感染控制市场预计到2030年将达到351亿美元

全球医院感染控制市场预计在2024年达到307亿美元，预计到2030年将达到351亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为2.2%。本报告分析的细分市场之一－防护屏障，预计复合年增长率为2.0%，到分析期末将达到111亿美元。消毒设备细分市场预计在分析期间内复合年增长率为2.5%。

美国市场规模估计为83亿美元，而中国市场预计将以3.0%的复合年增长率成长。

据估计，2024年美国医院感染控制市场规模将达83亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到65亿美元，在2024年至2030年的分析期间内，年复合成长率（CAGR）为3.0%。其他值得关注的区域市场分析包括日本和加拿大，预计两国在分析期间的年复合成长率为1.9%。在欧洲，德国预计年复合成长率约为1.9%。

全球医院感染控制市场－主要趋势与驱动因素概述

医院感染控制是营造更安全医疗环境的关键吗？

医院感染（HAI）是医疗机构面临的一大难题，但为什么感染控制对病人安全如此重要？医院感染是指患者在医院或其他医疗机构接受治疗期间发生的新的感染。这些感染包括肺炎、手术部位感染、血流感染和尿道感染，通常由细菌、病毒或真菌引起。有效的感染控制措施对于限制这些感染的传播和保护易感患者至关重要。

感染控制的重要性在于其能够预防危险病原体在医疗环境中的传播。若缺乏严格的通讯协定，医院感染会导致住院时间延长、医疗成本增加，严重时甚至会危及生命或导致死亡。随着抗药性细菌的出现，采取有效的感染预防措施变得更加迫切。感染控制措施有助于维持更清洁的环境、改善患者预后并限制抗药性病原体的传播，因此是现代医疗保健系统不可或缺的一部分。

科技如何促进了医院感染控制？

科技进步显着提升了医院感染控制的工具和方法，使感染预防更加有效。其中最具影响力的进展之一是紫外线 (UV) 消毒系统的应用。 UV-C 紫外线用于医疗环境中的表面和空气消毒，杀灭传统清洁方法无法去除的病原体。这些系统广泛应用于手术室、加护病房(ICU) 和病房，为预防医院感染提供了额外的保护。

自动化手卫生监测系统是另一项提升感染控制效果的创新技术。这些系统能够追踪和监测医护人员的手部卫生遵从性，帮助确保他们遵守正确的卫生通讯协定。手部卫生是预防感染传播最有效的方法之一，而自动化监测可以提供即时数据，以便在依从率下降时及时采取干预措施。

先进的诊断技术和即时监测工具也彻底改变了医院的感染控制方法。病原体的快速诊断检测能够及早发现感染，使受感染的患者能够更快地得到治疗和隔离。数位化平台和人工智慧驱动的分析能够追踪医院内的感染模式，并提供预测潜在疫情爆发的洞察。这些工具可协助感染控制团队识别高风险区域，并制定有针对性的措施来阻止感染的传播。

灭菌技术也在不断发展，提高了医疗设备和仪器的安全性。低温灭菌方法，例如过氧化氢蒸气和等离子灭菌，能够有效消毒对热敏感的设备，确保手术器械和医疗设备不含任何有害病原体。这些技术对于感染风险较高的侵入性手术中使用的器械尤其重要。

抗菌表面的研发为感染控制增添了一层额外的保护。研究表明，涂覆铜、银等材料的表面能够抑制医疗环境中细菌和其他病原体的生长和传播。这些抗菌表面正越来越多地应用于床栏、门把手和医疗设备等高频接触区域，以降低因表面接触而导致的医院感染风险。

为什么医院感染控制对病人安全和医疗效率至关重要？

医院感染控制对于保障病人安全、降低医疗成本以及维持整个医疗系统的高效运作至关重要。医院感染可能对患者健康造成严重后果，尤其是免疫力较弱、患有慢性疾病、术后復原的患者。有效的感染控制能够预防病原体的传播，保护脆弱的患者免受危及生命的感染疾病，从而避免阻碍他们的治疗和復原。

除了保护患者健康外，感染控制措施还有助于预防抗药性细菌的传播，例如抗药性金黄色葡萄球菌(MRSA) 和耐碳青霉烯类肠桿菌 (CRE)。这些超级细菌难以治疗，可能导致严重的併发症、延长住院时间，甚至死亡。感染控制措施，例如正确的手部卫生、使用个人防护设备(PPE) 和严格的清洁程序，有助于限制这些危险病原体在医疗机构内的传播。

感染控制也能透过降低医疗相关感染（HAI）的发生率来提高医疗效率。管理HAI需要耗费大量成本和资源。感染HAI的患者通常需要额外的医疗护理，包括更长的住院时间、更频繁的就诊以及更昂贵的药物。这会给医疗机构带来更大的压力，并增加医院和病人的成本。透过降低感染率，医院可以优化资源配置，降低病患再入院率，并改善整体医疗效果。

感染控制的另一个重要面向是保护医护人员免受传染性病原体的侵害。由于医护人员经常接触血液、体液和受污染的表面，他们面临感染风险。适当的感染控制通讯协定，包括个人防护设备（PPE）、表面消毒和疫苗接种计划，可以保护医护人员，使他们能够在不危及自身或他人安全的情况下继续提供医疗服务。

哪些因素正在推动医院感染控制市场的成长？

由于医院感染（HAI）发生率上升、人们对感染控制措施的认识不断提高以及医疗技术的进步等几个关键因素，医院感染控制市场正经历显着增长。其中一个主要驱动因素是全球范围内医院感染的日益普遍。随着医疗机构收治的复杂疾病患者越来越多，医院环境中感染传播的风险也增加。这促使医院投资更有效的感染控制措施，例如紫外线消毒系统和先进的监测工具。

人们对感染预防重要性的认识不断提高，尤其是在新冠肺炎疫情等全球健康挑战的背景下，也推动了感染控制技术的应用。各国政府、医疗机构和监管机构更加重视提升感染控制标准，许多国家实施了更严格的法规以降低医院感染率。民众对医院安全的关注也不断提高，这促使人们更加重视医院在感染预防方面的投入。

消毒和灭菌製程的技术进步也推动了市场成长。诸如紫外线C波段和过氧化氢蒸气系统等新型消毒技术正变得越来越普及，并被全球医疗机构迅速采用。这些技术能够比传统清洁方法更快、更彻底地消毒，进而降低病原体传播的风险。同样，抗菌表面和先进个人防护设备（PPE）的广泛应用也有助于保障医护人员和病患免受感染。

推动市场成长的另一个因素是医疗基础设施投资的增加，尤其是在新兴市场。随着开发中国家医疗体系的扩展，对符合国际医疗标准的感染控制产品和服务的需求日益增长。这些地区的许多医疗机构正在更新设备和通讯协定，以提高病人安全并防止医院感染的传播。

最后，人们对病人安全和医疗品质日益增长的关注，正推动更先进的感染控制措施的采用。医院面临越来越大的压力，需要达到认证标准并保持较低的感染率，以吸引患者并维护自身声誉。包括即时监测、先进诊断技术和自动化消毒系统在内的感染控制系统，正成为实现这些目标的关键工具。

由于对感染预防技术​​的需求不断增长、医疗基础设施的进步以及人们对医院感染风险的认识不断提高，医院感染控制市场预计将快速扩张。随着医疗机构将病人安全和效率放在首位，感染控制措施将继续在预防医院感染、确保病人和医护人员的健康方面发挥核心作用。

部分：

依产品（防护屏障、消毒设备、消毒剂、其他产品）、依应用（医院/加护病房、门诊手术/诊断中心、疗养院/妇产中心、其他应用）分类

受访公司范例

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB（Getinge Group）
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，革新市场和竞争情报分析。

Global Industry Analysts 并没有依赖通用的 LLM 或查询产业专用的SLM，而是建立了一个由世界各地领域专家精心整理的内容库，包括视讯转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

我们最新发布的报告纳入了关税对区域市场的影响，正如全球产业分析师预测的那样，关税将改变企业的竞争地位，而企业的竞争地位将取决于其总部所在地、製造地以及进出口（成品和OEM产品）。这种复杂多变的市场现实将透过微观和宏观市场动态影响竞争对手，包括销货成本增加、盈利下降以及供应链重组。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 亚太其他地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP12430

Global Hospital Acquired Infection Control Market to Reach US$35.1 Billion by 2030

The global market for Hospital Acquired Infection Control estimated at US$30.7 Billion in the year 2024, is expected to reach US$35.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Protective Barrier, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Sterilization Equipment segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 3.0% CAGR

The Hospital Acquired Infection Control market in the U.S. is estimated at US$8.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Hospital Acquired Infection Control Market - Key Trends and Drivers Summarized

Is Hospital Acquired Infection Control the Key to Safer Healthcare Environments?

Hospital-acquired infections (HAIs) are a significant concern in healthcare settings, but why is infection control so crucial for patient safety? Hospital-acquired infections occur when patients develop new infections while receiving care in hospitals or other medical facilities. These infections include conditions such as pneumonia, surgical site infections, bloodstream infections, and urinary tract infections, often caused by bacteria, viruses, or fungi. Effective infection control measures are essential for reducing the spread of these infections and protecting vulnerable patients.

The importance of infection control lies in its ability to prevent the transmission of dangerous pathogens within healthcare environments. Without stringent protocols, HAIs can prolong hospital stays, increase healthcare costs, and, in severe cases, lead to life-threatening conditions or death. With the rise of antibiotic-resistant organisms, the need for effective infection prevention measures has become more urgent. Infection control practices help maintain cleaner environments, improve patient outcomes, and reduce the spread of drug-resistant pathogens, making them a vital component of modern healthcare systems.

How Has Technology Advanced Hospital-Acquired Infection Control?

Technological advancements have significantly enhanced the tools and methods used for hospital-acquired infection control, making infection prevention more effective and efficient. One of the most impactful developments is the use of ultraviolet (UV) disinfection systems. UV-C light is used to sterilize surfaces and air in healthcare settings, killing pathogens that may otherwise remain after traditional cleaning. These systems have been widely adopted in operating rooms, intensive care units (ICUs), and patient rooms, providing an additional layer of protection against HAIs.

Automated hand hygiene monitoring systems are another innovation that has improved infection control efforts. These systems track and monitor hand hygiene compliance among healthcare workers, helping to ensure that proper sanitation protocols are followed. Hand hygiene is one of the most effective methods of preventing the spread of infections, and automated monitoring provides real-time data, allowing for timely interventions if compliance rates drop.

Advanced diagnostics and real-time surveillance tools have also transformed how hospitals manage infection control. Rapid diagnostic tests for pathogens allow for quicker identification of infections, enabling faster treatment and isolation of affected patients. Digital platforms and AI-driven analytics are used to track infection patterns within hospitals, providing insights into potential outbreaks before they occur. These tools help infection control teams identify high-risk areas and develop targeted interventions to stop the spread of infections.

Sterilization technologies have also evolved, improving the safety of medical equipment and tools. Low-temperature sterilization methods, such as vaporized hydrogen peroxide and plasma sterilizers, allow for the effective disinfection of heat-sensitive equipment, ensuring that surgical instruments and medical devices are free from harmful pathogens. These technologies are especially important for devices used in invasive procedures, where the risk of infection is higher.

The development of antimicrobial surfaces has added another layer of protection in infection control. Surfaces coated with materials like copper or silver have been shown to reduce the growth and spread of bacteria and other pathogens in healthcare environments. These antimicrobial surfaces are increasingly being used on high-touch areas like bed rails, door handles, and medical equipment, reducing the risk of HAIs through surface contact.

Why Is Hospital-Acquired Infection Control Critical for Patient Safety and Healthcare Efficiency?

Hospital-acquired infection control is critical for ensuring patient safety, reducing healthcare costs, and maintaining overall healthcare system efficiency. HAIs can severely impact patient health, particularly among those with weakened immune systems, chronic illnesses, or those recovering from surgery. Effective infection control measures prevent the transmission of pathogens, safeguarding vulnerable patients from potentially life-threatening infections that can complicate their treatment and recovery.

In addition to safeguarding patient health, infection control measures help prevent the spread of drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE). These superbugs are difficult to treat and can lead to severe complications, prolonged hospital stays, and even death. Infection control measures, such as proper hand hygiene, the use of personal protective equipment (PPE), and strict cleaning protocols, help limit the spread of these dangerous pathogens within healthcare facilities.

Infection control also improves healthcare efficiency by reducing the incidence of HAIs, which are costly and resource-intensive to manage. Patients who contract HAIs often require additional medical care, including extended hospital stays, more frequent doctor visits, and expensive medications. This increases the burden on healthcare facilities, leading to higher costs for both the hospital and the patient. By reducing infection rates, hospitals can optimize resource allocation, reduce patient readmission rates, and improve overall healthcare outcomes.

Another vital aspect of infection control is protecting healthcare workers from exposure to infectious agents. Healthcare workers are frequently exposed to blood, bodily fluids, and contaminated surfaces, putting them at risk for contracting infections. Proper infection control protocols, including PPE, surface disinfection, and vaccination programs, protect healthcare workers, ensuring they can continue to provide care without putting themselves or others at risk.

What Factors Are Driving the Growth of the Hospital-Acquired Infection Control Market?

The hospital-acquired infection control market is experiencing significant growth due to several key factors, including the rising incidence of HAIs, growing awareness of infection control measures, and advancements in healthcare technology. One of the primary drivers is the increasing prevalence of HAIs across the globe. As healthcare facilities treat more patients with complex medical needs, the risk of infections spreading in hospital settings has risen. This has prompted hospitals to invest in more effective infection control measures, from UV disinfection systems to advanced surveillance tools.

The rising awareness of the importance of infection prevention, particularly in light of global health challenges like the COVID-19 pandemic, has also driven the adoption of infection control technologies. Governments, healthcare institutions, and regulatory bodies are placing greater emphasis on improving infection control standards, with many countries implementing stricter regulations to reduce the incidence of HAIs. Public awareness of hospital safety has increased as well, leading to more demand for hospitals to demonstrate their commitment to infection prevention.

Technological advancements in disinfection and sterilization processes are also contributing to market growth. New disinfection technologies, such as UV-C and hydrogen peroxide vapor systems, have become more accessible and are being rapidly adopted in healthcare facilities worldwide. These technologies offer faster, more thorough disinfection than traditional cleaning methods, reducing the risk of pathogen transmission. Similarly, the rise of antimicrobial surfaces and advanced PPE is helping healthcare workers and patients stay safer from infections.

Another factor driving market growth is the increasing investment in healthcare infrastructure, particularly in emerging markets. As developing countries expand their healthcare systems, there is a growing need for infection control products and services to meet international healthcare standards. Many healthcare facilities in these regions are upgrading their equipment and protocols to improve patient safety and prevent the spread of HAIs.

Finally, the increasing focus on patient safety and quality care is influencing the adoption of more sophisticated infection control measures. Hospitals are under growing pressure to meet accreditation standards and demonstrate low infection rates to attract patients and maintain their reputations. Infection control systems, including real-time monitoring, advanced diagnostics, and automated disinfection, are becoming essential tools in achieving these goals.

With growing demand for infection prevention technologies, advancing healthcare infrastructure, and increasing awareness of the dangers posed by HAIs, the hospital-acquired infection control market is expected to expand rapidly. As healthcare facilities prioritize patient safety and efficiency, infection control measures will remain central to preventing HAIs and ensuring healthier outcomes for patients and healthcare workers alike.

SCOPE OF STUDY:

The report analyzes the Hospital Acquired Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Protective Barrier, Sterilization Equipment, Disinfectants, Other Products); End-Use (Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hospital Acquired Infection Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expansion of Healthcare Infrastructure Spurs Adoption of Advanced HAI Control Measures
    • Growth in Hospital Admissions and Surgical Procedures Expands Addressable Market for HAI Control
    • Role of HAI Control in Enhancing Patient Safety and Reducing Healthcare Costs Strengthens Business Case for Adoption
    • Increasing Focus on Antimicrobial Resistance and Superbugs Fuels Market Demand for HAI Control Solutions
    • Growth in Use of Ultraviolet (UV) and Hydrogen Peroxide-based Disinfection Expands Market Opportunities
    • Technological Integration for Automated and Robotic Disinfection Systems Expands Market Potential
    • Growth in Demand for Single-use Medical Devices and Disposable Products Fuels Market Adoption
    • Increasing Focus on Hand Hygiene and Personal Protective Equipment (PPE) Expands Addressable Market
    • Growth in Use of Antimicrobial Coatings and Barrier Materials in Healthcare Settings Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hospital Acquired Infection Control Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Protective Barrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sterilization Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Disinfectants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ambulatory Surgery & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nursing Homes & Maternity Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION